Arrowhead Pharmaceuticals, Inc. (ARWR)
78.22
-0.92
(-1.16%)
USD |
NASDAQ |
May 07, 09:43
Arrowhead Pharmaceuticals Free Cash Flow : 327.01M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics, Inc. | -332.39M |
| Johnson & Johnson | 17.80B |
| Biogen, Inc. | 2.316B |
| Merck & Co., Inc. | 14.12B |
| Vertex Pharmaceuticals, Inc. | 3.710B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 13.48M |
| Cash from Investing (Quarterly) | -23.74M |
| Cash from Financing (Quarterly) | -14.75M |
| Free Cash Flow Per Share (Quarterly) | 0.0805 |
| Free Cash Flow to Equity (Quarterly) | 57.25M |
| Free Cash Flow to Firm (Quarterly) | 33.81M |
| Free Cash Flow Yield | 3.04% |